This is a clinical stage immonatherapentic company that is expecting to get results for the flue jab.Headlines can be seen on their website 28/2/2020.

The average trades are 267K , but last Friday was a wopping 26M!

The share price responded with an increase of 110%, so there is a lot of interest in this company at this point of time. Certainly worth putting on a watch list.

Unlock the rest of this Article in 15 seconds

or Unlock with your email

Already have an account?
Login here